[(111)In-DTPA]octreotide tumor uptake in GEPNET liver metastases after intra-arterial administration: an overview of preclinical and clinical observations and implications for tumor radiation dose after peptide radionuclide therapy.

Saved in:
Bibliographic Details
Title: [(111)In-DTPA]octreotide tumor uptake in GEPNET liver metastases after intra-arterial administration: an overview of preclinical and clinical observations and implications for tumor radiation dose after peptide radionuclide therapy.
Authors: Pool SE; 1 Department of Nuclear Medicine, Erasmus MC , Rotterdam, The Netherlands ., Kam BL, Koning GA, Konijnenberg M, Ten Hagen TL, Breeman WA, Krenning EP, de Jong M, van Eijck CH
Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2014 May; Vol. 29 (4), pp. 179-87.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print Cited Medium: Internet ISSN: 1557-8852 (Electronic) Linking ISSN: 10849785 NLM ISO Abbreviation: Cancer Biother Radiopharm Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-8852
DOI:10.1089/cbr.2013.1552